G. Meyer

发表

Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET

T. Petrich, M. Hofmann, T. Brunkhorst, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients

J. Karstens, J. Hoff, M. Hofmann, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Amino acids for the measurement of protein synthesis in vivo by PET.

C. Crouzel, C. Lemaire, B. Långström, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer

R. Senekowitsch-Schmidtke, John C. Morris, B. Göke, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors.

L. Quintanilla‐Martinez, T. Petrich, W. Knapp, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Routine production of [13N]NH3 for PET examinations with a continuous flow water target

H. Hundeshagen, K. Matzke, G. Meyer, 1994 .

In vitro experimental 211At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin

T. Petrich, W. Knapp, G. Meyer, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Preparation and evaluation of 211At labelled antineoplastic antibodies.

M. Hofmann, W. Knapp, G. Meyer, 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

(211)At-antiCD33 in NMRI nu/nu mice. Biodistribution, in vivo stability and radiotoxicity.

T. Petrich, W. Knapp, G. Meyer, 2011, Nuklearmedizin. Nuclear medicine.

The first scintigraphic detection of tumor necrosis factor-alpha in patients with complex regional pain syndrome type 1.

M. Karst, T. Brunkhorst, W. Knapp, 2010, Anesthesia and analgesia.

Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitro.

W. Knapp, G. Meyer, M. Grote, 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Reaction of aromatic diazonium salts with carrier-free radioiodine and astatine. Evidence for complex formation

G. Stoecklin, G. Meyer, K. Roessler, 1979 .

Noninvasive measurement of lung carbon-11-serotonin extraction in man.

G. Coates, G. Firnau, K. Gratz, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Sodium-iodide symporter positive cells after intracellular uptake of (99m)Tc versus α-emitter 211At. Reduction of clonogenic survival and characterization of DNA damage.

R. Freudenberg, J. Kotzerke, L. Kunz-Schughart, 2012, Nuklearmedizin. Nuclear medicine.

Routine quality control of11C-labelled radiopharmaceuticals by high pressure liquid chromatography

H. Hundeshagen, G. Meyer, A. Osterholz, 1983 .

The biodistribution and metabolic fate of [11C]acrylic acid in the rat after acute inhalation exposure or stomach intubation.

A. Wolf, G. Meyer, R. S. Kutzman, 1982, Journal of toxicology and environmental health.

Systemic treatment with 4-211At - phenylalanine enhances survival of rats with intracranial glioblastoma

J. Krauss, K. Schwabe, M. Nakamura, 2013, Nuklearmedizin.

Sodium-iodide symporter positive cells after intracellular uptake of 99mTc versus α-emitter 211At

R. Freudenberg, J. Kotzerke, L. Kunz-Schughart, 2012, Nuklearmedizin.

Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter

T. Petrich, W. Knapp, G. Meyer, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

The stability of 2-[18F]fluoro-deoxy-d-glucose towards epimerisation under alkaline conditions

K. Hamacher, K. Matzke, F. Füchtner, 1999 .

Report and recommendations on the requirements for postgraduate training in radiopharmacy and radiopharmaceutical chemistry 1989

P. H. Cox, P. Komarek, H. Coenen, 1990, European Journal of Nuclear Medicine.

Radiopharmaceuticals 1994

P. H. Cox, G. Meyer, European association of nuclear medicine committees on radi tomography, 1995, European Journal of Nuclear Medicine.

Report of an International Atomic Energy Agency's Advisory Group meeting on "Quality control of cyclotron-produced radiopharmaceuticals".

P. H. Cox, V. Pike, W. Vaalburg, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Current methodology for oxygen-15 production for clinical use.

C. Crouzel, K. Strijckmans, G. Meyer, 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Excitation function for the nuclear reaction

G. Meyer, Richard M. Lambrecht, 1980 .

Preparatton and high pressure liquid chromatography of 5‐astatouracil

G. Stöcklin, G. Meyer, K. Rössler, 1976 .

Formation of 211 Rn by 6 Li Induced Reactions on 209 Bi at 70 MeV

G. Meyer, 1989 .

Quality Assurance and Quality Control of Short-Lived Radiopharmaceuticals for PET

A. Luxen, C. Crouzel, C. Halldin, 1993 .

Reactivity and Selectivity of the Astatine Interhalogen Compounds AtCI and AtBr Towards Simple Aromatic Substrates

G. Stöcklin, G. Meyer, K. Rössler, 1977 .

68Ga-labelled DOTA-derivatised peptide ligands

W. H. Knapp, M. Hofmann, W. Knapp, 2004, European Journal of Nuclear Medicine and Molecular Imaging.